262 related articles for article (PubMed ID: 12488067)
1. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines.
Weigel RM; Hahn EC; Scherba G
Vet Microbiol; 2003 Mar; 92(1-2):19-24. PubMed ID: 12488067
[TBL] [Abstract][Full Text] [Related]
2. Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes.
Wu CY; Liao CM; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Jul; 229():58-64. PubMed ID: 27164258
[TBL] [Abstract][Full Text] [Related]
3. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
4. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
5. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
Gerdts V; Jöns A; Mettenleiter TC
Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
[TBL] [Abstract][Full Text] [Related]
6. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes.
Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J
BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine.
Swenson SL; McMillen J; Hill HT
J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983
[TBL] [Abstract][Full Text] [Related]
9. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge.
Gu Z; Dong J; Wang J; Hou C; Sun H; Yang W; Bai J; Jiang P
Virus Res; 2015 Jan; 195():57-63. PubMed ID: 25240533
[TBL] [Abstract][Full Text] [Related]
10. A live, attenuated pseudorabies virus strain JS-2012 deleted for gE/gI protects against both classical and emerging strains.
Tong W; Li G; Liang C; Liu F; Tian Q; Cao Y; Li L; Zheng X; Zheng H; Tong G
Antiviral Res; 2016 Jun; 130():110-7. PubMed ID: 26946112
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
[TBL] [Abstract][Full Text] [Related]
12. Pseudorabies virus (PRV) strain with defects in gE, gC, and TK genes protects piglets against an emerging PRV variant.
Lin J; Li Z; Feng Z; Fang Z; Chen J; Chen W; Liang W; Chen Q
J Vet Med Sci; 2020 Jun; 82(6):846-855. PubMed ID: 32336701
[TBL] [Abstract][Full Text] [Related]
13. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets.
Zhang C; Guo L; Jia X; Wang T; Wang J; Sun Z; Wang L; Li X; Tan F; Tian K
Vaccine; 2015 May; 33(21):2432-7. PubMed ID: 25865469
[TBL] [Abstract][Full Text] [Related]
14. Additional Insertion of gC Gene Triggers Better Immune Efficacy of TK/gI/gE-Deleted Pseudorabies Virus in Mice.
Wu Z; Deng J; Chen M; Lu P; Yan Z; Wu X; Ji Q; Fan H; Luo Y; Ju C
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793591
[TBL] [Abstract][Full Text] [Related]
15. Effect of maternally acquired Aujeszky's disease (pseudorabies) virus-specific antibody in pigs on establishment of latency and seroconversion to differential glycoproteins after low dose challenge.
McCaw MB; Osorio FA; Wheeler J; Xu J; Erickson GA
Vet Microbiol; 1997 Apr; 55(1-4):91-8. PubMed ID: 9220600
[TBL] [Abstract][Full Text] [Related]
16. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.
Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L
Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
[TBL] [Abstract][Full Text] [Related]
18. Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant.
Zhao Y; Wang LQ; Zheng HH; Yang YR; Liu F; Zheng LL; Jin Y; Chen HY
Mol Cell Probes; 2020 Oct; 53():101605. PubMed ID: 32464159
[TBL] [Abstract][Full Text] [Related]
19. The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus.
Ferrari M; Gualandi GL; Corradi A; Monaci C; Romanelli MG; Losio MN; Cantoni AM; Pratelli A
Comp Immunol Microbiol Infect Dis; 2000 Jan; 23(1):15-26. PubMed ID: 10660255
[TBL] [Abstract][Full Text] [Related]
20. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
